Clinical Trial

Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs

Study acronym: PINK
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to find out whether a system that uses trained detection dogs and artificial intelligence (AI) can identify breast cancer from a person's breath. Women who are scheduled to have routine breast cancer screening, such as a mammogram, ultrasound, or a biopsy for a possible cancer, will be invited to take part. Participants will be asked to breathe into a surgical mask to collect a breath sample. The mask will be sent to a special laboratory, where trained dogs and an AI-based system will check the sample for signs of breast cancer. The results from the dogs and AI will be compared to the actual results from the medical screening or biopsy to see how accurate the system is at detecting breast cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-23; most recent amendment 2026-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-08-12
Trial Details
NCT Number NCT07038785
Lead Sponsor SpotitEarly
Collaborators: Hackensack Meridian Health, University of Pennsylvania
Conditions Breast Cancer
Enrollment 1,204 participants
Start Date 2025-07-22
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-15